cagrilintide+Semaglutide CS5 5mg*10vials

Smegglutide CS5 (5mg x 10 vials) is a basic, introductory-level, high-purity, lyophilized GLP-1 receptor agonist, the standard version of the Smegglutide CS series. CS5 is optimized with a classic, stable molecular structure, exhibiting excellent biological activity and low-dose tolerability, making it ideal for basic preclinical metabolic mechanism exploration, low-dose gradient screening, drug safety and tolerability testing, and long-term low-dose continuous intervention experiments. As an introductory-friendly and cost-effective core research peptide, it is widely applicable to university laboratory teaching experiments, preliminary project validation, and the construction of basic glucose and lipid metabolism models.

Product Functions and Research Value

Smegglutide CS5 effectively activates the GLP-1 receptor, mimicking the physiological incretin effect in vivo. It is primarily used for basic research on improving insulin sensitivity, regulating blood glucose balance, suppressing appetite signals, and gently intervening in lipid metabolism. CS5's stable low-dose activity makes it an ideal choice for exploring dose-response relationships, drug safety thresholds, and long-term gentle metabolic regulation mechanisms. Compared to the upgraded high-concentration SM series, CS5 offers a gentler and more stable intervention effect, effectively avoiding experimental failures or model damage caused by excessively high drug concentrations. It provides reliable and reproducible basic data for the preliminary validation of glucose and lipid metabolism disorders, mild insulin resistance, and appetite regulation mechanisms.

Core Product Advantages

1. CS5 Classic Stable Basic Version: Utilizing a mature and standardized molecular structure, it possesses stable and mild biological activity, excellent safety, and low-dose tolerability, making it ideal for basic experimental exploration and preliminary mechanism validation.

2. 5mg Precise Low-Dose Specification: Its unique entry-level low-concentration design fills the gap in low-dose gradient experiments. It is the best choice for dose-escalation modeling, safety and tolerability testing, and long-term continuous low-dose intervention studies, enabling more precise experimental grouping.

3. Strict Standard Lyophilization Process: Employing aseptic vacuum lyophilization technology, it completely locks in peptide activity. Each batch of product undergoes professional HPLC purity testing and comes with a complete Certificate of Account (COA), indicating extremely low purity. 4. Economical Bulk Packaging: 10 vials per box, standardized packaging, meeting the needs of daily basic laboratory experiments, academic teaching projects, preliminary scientific research validation, and large-scale wholesale purchases.

Smegglutide (CS5) 5mg*10 vials is the entry-level high-purity lyophilized GLP-1 receptor agonist in the Smegglutide CS series, representing the basic standard version of the entire series. This product adopts a mature and classic stable molecular structure, with mild and balanced activity, excellent low-dose tolerability, and is specifically designed for basic preclinical metabolic mechanism exploration, low-dose gradient screening, drug safety and tolerability testing, and long-term low-dose continuous intervention experiments. It is an economical and efficient core research peptide raw material, suitable for university laboratory teaching experiments, preliminary project validation, and the construction of basic glucose and lipid metabolism models.

Core Uses and Research Value of the Peptide

CS5 can stably activate GLP-1 receptors, mimicking the physiological function of natural incretin in vivo, and is suitable for basic metabolic research scenarios. It is mainly used for mechanistic studies in basic areas such as improving insulin sensitivity, regulating blood glucose homeostasis, inhibiting appetite signals, and regulating mild lipid metabolism. With its mild and stable low-dose activity, CS5 is ideal for fundamental experiments exploring dose-response relationships, investigating drug safety thresholds, and investigating mild long-term metabolic remodeling. Compared to the high-concentration upgraded version, CS5's intervention effect is more gradual and controllable, effectively avoiding problems such as model stress and experimental failure caused by high-concentration drugs. It can provide highly reproducible and stable basic experimental data for early validation of glucose and lipid metabolism disorders, mild insulin resistance, and appetite regulation mechanisms.

Core Product Advantages

1. CS5 Classic Stable Version: Utilizing a mature and standardized molecular structure, it exhibits mild and stable biological activity, good safety and tolerability, and no excessive pharmacological reactions, making it ideal for novice experiments, fundamental mechanism exploration, and early project validation.